Literature DB >> 22659239

Potential G-quadruplex formation at breakpoint regions of chromosomal translocations in cancer may explain their fragility.

Vijeth K Katapadi1, Mridula Nambiar, Sathees C Raghavan.   

Abstract

Genetic alterations like point mutations, insertions, deletions, inversions and translocations are frequently found in cancers. Chromosomal translocations are one of the most common genomic aberrations associated with nearly all types of cancers especially leukemia and lymphoma. Recent studies have shown the role of non-B DNA structures in generation of translocations. In the present study, using various bioinformatic tools, we show the propensity of formation of different types of altered DNA structures near translocation breakpoint regions. In particular, we find close association between occurrence of G-quadruplex forming motifs and fragile regions in almost 70% of genes involved in rearrangements in lymphoid cancers. However, such an analysis did not provide any evidence for the occurrence of G-quadruplexes at the close vicinity of translocation breakpoint regions in nonlymphoid cancers. Overall, this study will help in the identification of novel non-B DNA targets that may be responsible for generation of chromosomal translocations in cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22659239     DOI: 10.1016/j.ygeno.2012.05.008

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  35 in total

1.  G-quadruplex structures formed at the HOX11 breakpoint region contribute to its fragility during t(10;14) translocation in T-cell leukemia.

Authors:  Mridula Nambiar; Mrinal Srivastava; Vidya Gopalakrishnan; Sritha K Sankaran; Sathees C Raghavan
Journal:  Mol Cell Biol       Date:  2013-09-03       Impact factor: 4.272

Review 2.  The role of fork stalling and DNA structures in causing chromosome fragility.

Authors:  Simran Kaushal; Catherine H Freudenreich
Journal:  Genes Chromosomes Cancer       Date:  2019-01-29       Impact factor: 5.006

3.  Binding of anticancer drug daunomycin to a TGGGGT G-quadruplex DNA probed by all-atom molecular dynamics simulations: additional pure groove binding mode and implications on designing more selective G-quadruplex ligands.

Authors:  Zhanhang Shen; Kelly A Mulholland; Yujun Zheng; Chun Wu
Journal:  J Mol Model       Date:  2017-08-08       Impact factor: 1.810

Review 4.  Replication stalling and DNA microsatellite instability.

Authors:  R Gadgil; J Barthelemy; T Lewis; M Leffak
Journal:  Biophys Chem       Date:  2016-11-22       Impact factor: 2.352

Review 5.  The Top1 paradox: Friend and foe of the eukaryotic genome.

Authors:  Nayun Kim; Sue Jinks-Robertson
Journal:  DNA Repair (Amst)       Date:  2017-06-09

Review 6.  Sub1/PC4, a multifaceted factor: from transcription to genome stability.

Authors:  Miguel Garavís; Olga Calvo
Journal:  Curr Genet       Date:  2017-05-31       Impact factor: 3.886

Review 7.  The cellular etiology of chromosome translocations.

Authors:  Vassilis Roukos; Bharat Burman; Tom Misteli
Journal:  Curr Opin Cell Biol       Date:  2013-03-14       Impact factor: 8.382

8.  Comprehensive analysis of cancer breakpoints reveals signatures of genetic and epigenetic contribution to cancer genome rearrangements.

Authors:  Kseniia Cheloshkina; Maria Poptsova
Journal:  PLoS Comput Biol       Date:  2021-03-01       Impact factor: 4.475

9.  Sites of instability in the human TCF3 (E2A) gene adopt G-quadruplex DNA structures in vitro.

Authors:  Jonathan D Williams; Sara Fleetwood; Alexandra Berroyer; Nayun Kim; Erik D Larson
Journal:  Front Genet       Date:  2015-05-11       Impact factor: 4.599

10.  Differential responses of neurons, astrocytes, and microglia to G-quadruplex stabilization.

Authors:  Natalie Tabor; Conelius Ngwa; Jeremie Mitteaux; Matthew D Meyer; Jose F Moruno-Manchon; Liang Zhu; Fudong Liu; David Monchaud; Louise D McCullough; Andrey S Tsvetkov
Journal:  Aging (Albany NY)       Date:  2021-06-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.